Clinical Trial Update: Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure [Phase 2]

View source ↗

Summary

This Phase 2 trial is evaluating azacitidine or decitabine in combination with venetoclax for patients with Acute Myeloid Leukemia who previously failed hypomet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Dacogen (decitabine)
• VIDAZA (AZACITIDINE)
• Venclexta (venetoclax)

Snippet

Sponsor: Brian Jonas | Conditions: Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING